COMPANY
Eradivir
We develop small molecules that are powered by the immune system to treat a wide range of diseases. Our modular platform has enabled us to create a toolkit of antibody recruiting small molecules, and we are advancing a pipeline of candidates to treat multiple diseases. From company website Source · Oct 13, 2026